Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Report Calls For Proactive Reimbursement Policy On Remote Monitoring

This article was originally published in The Gray Sheet

Executive Summary

By investing $1,000 per patient, or $10.1 billion per year, to promote telemonitoring of chronically ill patients, health care payers could lower annual health care costs in the U.S. by $22.2 billion, according to estimates by Kauffman Foundation economist Robert E. Litan

You may also be interested in...



eCardio Predicts 24/7 Patient Compliance With eVolution Cardiac Monitor

eCardio Diagnostics believes the small, one-piece ambulatory design of its newest cardiac monitor will encourage consistent patient compliance, allowing physicians to track patients around the clock

DME, Oxygen Needs For Pandemic Flu Outbreaks Outlined In AHRQ Report

A new Agency for Healthcare Research and Quality report questions whether the U.S. has enough home health care durable medical equipment and medical supplies to handle a pandemic flu outbreak

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026751

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel